Your browser doesn't support javascript.
loading
A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers.
Xu, Shili; Catapang, Arthur; Braas, Daniel; Stiles, Linsey; Doh, Hanna M; Lee, Jason T; Graeber, Thomas G; Damoiseaux, Robert; Shirihai, Orian; Herschman, Harvey R.
Afiliación
  • Xu S; 1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095 USA.
  • Catapang A; 1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095 USA.
  • Braas D; 1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095 USA.
  • Stiles L; 3UCLA Metabolomics Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095 USA.
  • Doh HM; 6Division of Endocrinology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095 USA.
  • Lee JT; 1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095 USA.
  • Graeber TG; 1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095 USA.
  • Damoiseaux R; 4Crump Institute for Molecular Imaging, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095 USA.
  • Shirihai O; 5Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095 USA.
  • Herschman HR; 1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095 USA.
Cancer Metab ; 6: 7, 2018.
Article en En | MEDLINE | ID: mdl-29988332

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Metab Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Metab Año: 2018 Tipo del documento: Article